Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports
Open Access
- 14 December 2011
- journal article
- case report
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 11 (1), 344
- https://doi.org/10.1186/1471-2334-11-344
Abstract
Background Japanese encephalitis (JE) vaccination is the most effective measure for preventing JE disease. The live attenuated JE vaccine, which has shown good efficacy and safety, has been widely used in China. Case presentations We report four laboratory-confirmed JE cases detected in JE-endemic areas during the JE virus (JEV) transmission season, who all received a first dose of live attenuated JE vaccine within 2 weeks prior to the onset of illness. All cases presented with acute encephalitis and rapidly reduced consciousness. All cerebrospinal fluid (CSF) samples from the patients were positive for JEV-specific immunoglobulin M (IgM) antibodies, but viral isolation and polymerase chain reaction (PCR) detection of JEV were both negative. Conclusions It is difficult to identify a causal link between the disease and the vaccination, as the source of positive CSF JEV IgM antibodies might be natural JEV infection or possibly due to a traumatic lumbar puncture. Our observations highlight the need for public health officers and doctors to consider reasonable vaccination policies during the JE season. In addition, continued surveillance as well as thorough investigation of any events that occur after JE vaccination is necessary.Keywords
This publication has 8 references indexed in Scilit:
- The Neglected Arboviral Infections in Mainland ChinaPLoS Neglected Tropical Diseases, 2010
- Japanese Encephalitis: New Options for Active ImmunizationClinical Infectious Diseases, 2010
- Japanese Encephalitis Outbreak, Yuncheng, China, 2006Emerging Infectious Diseases, 2007
- Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case–control study in Nepalese children 5 years after immunizationVaccine, 2007
- Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infantsVaccine, 1999
- Short‐Term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA14–14–2): Results of a Randomized Trial with 26,239 SubjectsThe Journal of Infectious Diseases, 1997
- Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control studyThe Lancet, 1996
- Safety of a Live-Attenuated Japanese Encephalitis Virus Vaccine (SA14-14-2) for ChildrenThe American Journal of Tropical Medicine and Hygiene, 1988